MAPT and type 2 diabetes mellitus: Mielke et al. highlight neuroinflammation via glial fibrillary acidic protein (GFAP) and axonal degeneration via neurofilament light chain (NfL) as key pathways in T2D-related cognitive decline, with limited involvement of amyloid/tau pathology [24].